Market revenue in 2024 | USD 212.6 million |
Market revenue in 2030 | USD 607.2 million |
Growth rate | 19.1% (CAGR from 2024 to 2030) |
Largest segment | Upstream process |
Fastest growing segment | Downstream Process |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Upstream Process, Downstream Process, Process Development |
Key market players worldwide | Thermo Fisher Scientific Inc, Sartorius AG, Danaher Corp, Merck KGaA, Compagnie de Saint-Gobain SA, Corning Inc, Entegris Inc, Meissner, ProAnalytics, CellBios |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bioprocess bags market will help companies and investors design strategic landscapes.
Upstream process was the largest segment with a revenue share of 43.27% in 2024. Horizon Databook has segmented the UK bioprocess bags market based on upstream process, downstream process, process development covering the revenue growth of each sub-segment from 2018 to 2030.
The UK holds a notable share of the bioprocess bags market in Europe. The market growth can be attributed to government investments to assist local players and create a competitive advantage against international players. For example, in December 2020, the UK government in response to the global manufacturing crisis during the COVID-19 pandemic provided around USD 270 million via the Vaccine Taskforce (VTF).
This funding allowed the establishment of the Vaccine Manufacturing and Innovation Centre (VMIC), west of London, to offer single-use bioreactors for vaccine manufacturing. The UK is one of the leading European countries for manufacturing advanced therapies, thus, there are lucrative growth opportunities for the bioprocess bags market in the country.
Similarly, in March 2022, the UK government announced a USD 339 million investment to boost life science & healthcare research and manufacturing expansion. All these initiatives by the government, in addition to the corporate investment model in the region, are expected to propel market growth in the coming years.
Horizon Databook provides a detailed overview of country-level data and insights on the UK bioprocess bags market , including forecasts for subscribers. This country databook contains high-level insights into UK bioprocess bags market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account